COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 828: Articles 8271-8280  | Next

Safety, tolerability and immunogenicity of Biological Es CORBEVAX vaccine in children and adolescents: A Prospective, Randomised, Double-blind, Placebo controlled, Phase-2/3 Study.
Thuluva, S., Paradkar, V., Gunneri, S., Yerroju, V., Mogulla, R., Pothakamuri, S. V., Turaga, K., Kyasani, M., Manoharan, S., Adabala, S., Javvadi, A. S., Medigeshi, G. R., Singh, J., Shaman, H., Binayke, A., Aymaan, Z., Awasthi, A., Narang, M., N, P., Mahantshetti, N., Garg, B. S., Ravi, M.
10.1101/2022.04.20.22274076 — Posted: 2022-04-26
Shared N417-dependent epitope on the SARS-CoV-2 Omicron, Beta and Delta-plus variants
Moyo-Gwete, T., Madzivhandila, M., Mkhize, N. N., Kgagudi, P., Ayres, F., Lambson, B. E., Manamela, N. P., Richardson, S. I., Makhado, Z., van der Mescht, M., de Beer, Z., de Villiers, T. R., Burgers, W. A., Ntusi, N. A., Rossouw, T., Ueckermann, V., Boswell, M. T., Moore, P. L.
10.1101/2022.04.24.22273395 — Posted: 2022-04-26
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agents
Gachoud, D., Pillonel, T., Gerasimos, T., Battola, D., Dumas, D., Opota, O., Fontana, S., Vollenweider, P., Manuel, O., Greub, G., Bertelli, C., Rufer, N.
10.1101/2022.04.24.22274200 — Posted: 2022-04-26
Anti SARS-CoV2 seroprevalence in Zanzibar in 2021 before the Omicron wave
Salum, S. S., Sheikh, M. A., Hebestreit, A., Kelm, S.
10.1101/2022.04.23.22274199 — Posted: 2022-04-26
Whole-Genome Sequencing Of Omicron Identified Multiple Outbreaks And Introduction Events In India During November 2021 and January 2022
Marathe, S., Nagaraj, G., Shamanna, V., Bhaskaran, M., S, N., Lingegowda, R. K.
10.1101/2022.04.20.22270880 — Posted: 2022-04-25
Seasonal patterns of SARS-CoV-2 transmission in secondary schools: a modelling study
Pham, T. M., Westerhof, I., Bootsma, M. C. J., Kretzschmar, M. E., Rozhnova, G., Bruijning-Verhagen, P.
10.1101/2022.04.21.22273952 — Posted: 2022-04-25
Ribavirin antiviral combination therapy in COVID 19, a single-center experience
Singh, B. O., Chikara, G., Panda, P. K., Bahurupi, Y. A., Saha, S., Pai, V. S.
10.1101/2022.04.24.22274149 — Posted: 2022-04-25
Do Some Super-Spreaders Spread Better? Effects of individual heterogeneity in epidemiological traits
Beagle, A. S., Budischak, S. A., Craft, M. E., Hall, R., Forbes, K., Nguyen, D., Cressler, C.
10.1101/2022.04.19.22273976 — Posted: 2022-04-23
Transcriptome and DNA methylome analysis of peripheral blood samples reveals incomplete restoration and transposable element activation after 3-month recovery of COVID-19
Yin, Y., Liu, X.-z., Tian, Q., Fan, Y.-x., Ye, Z., Meng, T.-q., Wei, G.-h., Xiong, C.-l., Li, H., He, X., Zhou, L.
10.1101/2022.04.19.22274029 — Posted: 2022-04-23
Immune and pathophysiologic profiling of antenatal COVID-19 in the GIFT cohort: A Singaporean case-control study.
Gu, Y., Low, J. M., Tan, J. S. Y., Ng, M. S. F., Ng, L. F. P., Shunmuganathan, B. D., Gupta, R., MacAry, P. A., Amin, Z., Lee, L. Y., Lian, D. W. Q., Shek, L. P.-C., Zhong, Y., Wang, L. W.
10.1101/2022.04.19.22273864 — Posted: 2022-04-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).